Filter News
Area of Research
- (-) Fusion and Fission (27)
- (-) Neutron Science (30)
- (-) Nuclear Science and Technology (17)
- Advanced Manufacturing (3)
- Biological Systems (1)
- Biology and Environment (108)
- Biology and Soft Matter (1)
- Clean Energy (132)
- Climate and Environmental Systems (5)
- Computational Biology (2)
- Computational Engineering (2)
- Computer Science (4)
- Electricity and Smart Grid (1)
- Energy Sciences (1)
- Functional Materials for Energy (2)
- Fusion Energy (15)
- Isotope Development and Production (1)
- Isotopes (12)
- Materials (64)
- Materials for Computing (6)
- Mathematics (1)
- National Security (28)
- Quantum information Science (2)
- Supercomputing (54)
News Topics
- (-) Biomedical (14)
- (-) Cybersecurity (2)
- (-) Energy Storage (10)
- (-) Environment (10)
- (-) Fusion (30)
- (-) Space Exploration (8)
- 3-D Printing/Advanced Manufacturing (13)
- Advanced Reactors (17)
- Artificial Intelligence (7)
- Big Data (2)
- Bioenergy (8)
- Biology (5)
- Biotechnology (1)
- Buildings (1)
- Chemical Sciences (6)
- Clean Water (2)
- Climate Change (1)
- Composites (2)
- Computer Science (16)
- Coronavirus (9)
- Critical Materials (1)
- Decarbonization (5)
- Education (1)
- Exascale Computing (1)
- Fossil Energy (2)
- Frontier (2)
- Grid (2)
- High-Performance Computing (4)
- Isotopes (6)
- ITER (6)
- Machine Learning (3)
- Materials (14)
- Materials Science (27)
- Mathematics (1)
- Microscopy (4)
- Molten Salt (4)
- Nanotechnology (11)
- National Security (2)
- Net Zero (1)
- Neutron Science (102)
- Nuclear Energy (63)
- Partnerships (3)
- Physics (11)
- Polymers (1)
- Quantum Computing (1)
- Quantum Science (7)
- Security (3)
- Simulation (3)
- Summit (6)
- Sustainable Energy (7)
- Transformational Challenge Reactor (3)
- Transportation (7)
Media Contacts
ORNL manages the Innovation Network for Fusion Energy Program, or INFUSE, with Princeton Plasma Physics Laboratory, to help the private sector find solutions to technical challenges that need to be resolved to make practical fusion energy a reality.
More than 50 current employees and recent retirees from ORNL received Department of Energy Secretary’s Honor Awards from Secretary Jennifer Granholm in January as part of project teams spanning the national laboratory system. The annual awards recognized 21 teams and three individuals for service and contributions to DOE’s mission and to the benefit of the nation.
Three ORNL scientists have been elected fellows of the American Association for the Advancement of Science, or AAAS, the world’s largest general scientific society and publisher of the Science family of journals.
ORNL's Larry Baylor and Andrew Lupini have been elected fellows of the American Physical Society.
Staff at Oak Ridge National Laboratory organized transport for a powerful component that is critical to the world’s largest experiment, the international ITER project.
Diego Del-Castillo-Negrete, a distinguished staff member in the Fusion Energy Division, was cited for Outstanding Technical Achievement – National Laboratory. He will be recognized during the GMiS annual conference, which will be held virtually Oct. 11-22. The HENAAC awards program is in its 33rd year.
Joseph Pickel has been elected a 2021 fellow of the American Chemical Society, or ACS. Pickel supports the Fusion and Fission Energy and Sciences Directorate as environment, safety and health
Equipment and expertise from Oak Ridge National Laboratory will allow scientists studying fusion energy and technologies to acquire crucial data during landmark fusion experiments in Europe.
Kathy McCarthy, associate laboratory director for Fusion and Fission Energy and Science at the Department of Energy’s Oak Ridge National Laboratory, has been elected fellow of the American Nuclear Society for her nationally and internationally recognized leadership in nuclear energy and fusion.
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.